Leveraging Artificial Intelligence (AI) Methods for Non-Small Cell Lung Cancer (NSCLC) Detection: A Review
Keywords:
artificial intelligence, cancer detection, non-small cell lung cancer, NSCLCAbstract
One of the main causes of cancer-death that significant to global public health concern is lung cancer. NSCLC has been categorized as a burden disease, with an estimated reaching 85% of all lung cancer cases around the world. The problem was that NSCLC disease could only be detected when the disease has grown at a late stage. Therefore, AI technology is also being implemented to handle NSCLC disease. This review discusses how AI has played a role in treating NSCLC disease in the last five years of research journals that collected 5 years between 2019-2024. The database resources are from PubMed, Scopus, and Google Scholar. The process of selecting journal papers was analyzed based on an in-depth understanding of NSCLC disease journals as considered an inclusion criterion. This review used the PRISMA to analysis and review 17 journals. After carrying out the analysis process on the AI-NSCLC journals, we found that AI has been able to help humans respond to cases of NSCLC patients, starting from the detection stage, comprehensive diagnosis, and providing treatment recommendations. Treatments of NSCLC tend to be more personalized and could run more effectively and efficiently based on medical images input into the AI model. However, considering the urgency and vulnerability of the application of these AI models, which will be directly related to human health, the medical images dataset is also quite limited and the biggest challenge for AI-NSCLC.
References
Ahmed, S., Raza, B., Hussain, L., Aldweesh, A., Omar, A., Khan, M. S., Eldin, E. T., & Nadim, M. A. (2023). The deep learning ResNet101 and ensemble XGBoost algorithm with hyperparameters optimization accurately predict the lung cancer. Applied Artificial Intelligence, 37(1). https://doi.org/10.1080/08839514.2023.2166222
Asadi, F., Salehnasab, C., & Ajori, L. (2020). Supervised algorithms of machine learning for the prediction of cervical cancer. Journal of Biomedical Physics and Engineering, 10(4), 513–522. https://doi.org/10.31661/jbpe.v0i0.1912-1027
Çalışkan, M., & Tazaki, K. (2023). AI/ML advances in non-small cell lung cancer biomarker discovery. Frontiers in Oncology, 13, 1–16. https://doi.org/10.3389/fonc.2023.1260374
Cellina, M., Cacioppa, L. M., Cè, M., Chiarpenello, V., Costa, M., Vincenzo, Z., Pais, D., Bausano, M. V., Rossini, N., Bruno, A., & Floridi, C. (2023). Artificial intelligence in lung cancer screening: The future is now. Cancers, 15(17). https://doi.org/10.3390/cancers15174344
Charan, N., & Parthiban, S. (2023). Decision tree over KNN for lung cancer detection to increase accuracy. Journal of Survey in Fisheries Sciences, 10(1S).
Chen, H., Xiong, W., Wu, J., Zhuang, Q., & Yu, G. (2020). Decision-making model based on ensemble method in auxiliary medical system for non-small cell lung cancer. IEEE Access, 8, 171903–171911. https://doi.org/10.1109/ACCESS.2020.3024840
Chiang, Y. T., Seow, K. M., & Chen, K. H. (2024). The pathophysiological, genetic, and hormonal changes in preeclampsia: A systematic review of the molecular mechanisms. International Journal of Molecular Sciences, 25(8). https://doi.org/10.3390/ijms25084532
Chiu, H. Y., Chao, H. S., & Chen, Y. M. (2022). Application of artificial intelligence in lung cancer. Cancers, 14(6). https://doi.org/10.3390/cancers14061370
Chowdary, G. J., G, S., M, P., & Yogarajah, P. (2023). Nucleus segmentation and classification using residual SE-UNet and feature concatenation approach in cervical cytopathology cell images. Technology in Cancer Research and Treatment, 22. https://doi.org/10.1177/15330338221134833
Fiste, O., Gkiozos, I., Charpidou, A., & Syrigos, N. K. (2024). Artificial intelligence-based treatment decisions: A new era for NSCLC. Cancers, 16(4). https://doi.org/10.3390/cancers16040831
Grossman, R., Haim, O., Abramov, S., Shofty, B., & Artzi, M. (2021). Differentiating small-cell lung cancer from non-small-cell lung cancer brain metastases based on MRI using EfficientNet and transfer learning approach. Technology in Cancer Research and Treatment, 20, 1–7. https://doi.org/10.1177/15330338211004919
Hou, X., Shen, G., Zhou, L., Li, Y., Wang, T., & Ma, X. (2022). Artificial intelligence in cervical cancer screening and diagnosis. Frontiers in Oncology, 12, 1–13. https://doi.org/10.3389/fonc.2022.851367
Karasu Benyes, Y., Welch, E. C., Singhal, A., Ou, J., & Tripathi, A. (2022). A comparative analysis of deep learning models for automated cross-preparation diagnosis of multi-cell liquid Pap smear images. Diagnostics, 12(8). https://doi.org/10.3390/diagnostics12081838
Khamparia, A., Gupta, D., Rodrigues, J. J. P. C., & de Albuquerque, V. H. C. (2021). DCAVN: Cervical cancer prediction and classification using deep convolutional and variational autoencoder network. Multimedia Tools and Applications, 80(20), 30399–30415. https://doi.org/10.1007/s11042-020-09607-w
Kim, G., Park, Y. M., Yoon, H. J., & Choi, J. H. (2023). Multi-kernel and multi-scale learning based deep ensemble model for predicting recurrence of non-small cell lung cancer. PeerJ Computer Science, 9, 1–20. https://doi.org/10.7717/peerj-cs.1311
Kriegsmann, M., Haag, C., Weis, C. A., Steinbuss, G., Warth, A., Zgorzelski, C., Muley, T., Winter, H., Eichhorn, M. E., Eichhorn, F., Kriegsmann, J., Christopolous, P., Thomas, M., Witzens-Harig, M., Sinn, P., von Winterfeld, M., Heussel, C. P., Herth, F. J. F., Klauschen, F., … Kriegsmann, K. (2020). Deep learning for the classification of small-cell and non-small-cell lung cancer. Cancers, 12(6), 1–15. https://doi.org/10.3390/cancers12061604
Lipkova, J., Chen, R. J., Chen, B., Lu, M. Y., Barbieri, M., Shao, D., Vaidya, A. J., Chen, C., Zhuang, L., Williamson, D. F. K., Shaban, M., Chen, T. Y., & Mahmood, F. (2022). Artificial intelligence for multimodal data integration in oncology. Cancer Cell, 40(10), 1095–1110. https://doi.org/10.1016/j.ccell.2022.09.012
Mayer, C., Ofek, E., Fridrich, D. E., Molchanov, Y., Yacobi, R., Gazy, I., Hayun, I., Zalach, J., Paz-Yaacov, N., & Barshack, I. (2022). Direct identification of ALK and ROS1 fusions in non-small cell lung cancer from hematoxylin and eosin-stained slides using deep learning algorithms. Modern Pathology, 35(12), 1882–1887. https://doi.org/10.1038/s41379-022-01141-4
Mulmule, P. V., & Kanphade, R. D. (2022). Classification of cervical cytology overlapping cell images with transfer learning architectures. Biomedical and Pharmacology Journal, 15(1), 277–284. https://doi.org/10.13005/bpj/2364
Özbay, E., & Özbay, F. A. (2023). Interpretable Pap smear image retrieval for cervical cancer detection with rotation invariance mask generation deep hashing. Computers in Biology and Medicine, 154. https://doi.org/10.1016/j.compbiomed.2023.106574
Quanyang, W., Yao, H., Sicong, W., Linlin, Q., Zewei, Z., Donghui, H., Hongjia, L., & Shijun, Z. (2024). Artificial intelligence in lung cancer screening: Detection, classification, prediction, and prognosis. Cancer Medicine, 13(7), 1–19. https://doi.org/10.1002/cam4.7140
Sachan, P., Singh, M., Patel, M., & Sachan, R. (2018). A study on cervical cancer screening using Pap smear test and clinical correlation. Asia-Pacific Journal of Oncology Nursing, 5(3), 337–341. https://doi.org/10.4103/apjon.apjon_15_18
Shao, D., Dai, Y., Li, N., Cao, X., Zhao, W., Cheng, L., Rong, Z., Huang, L., Wang, Y., & Zhao, J. (2022). Artificial intelligence in clinical research of cancers. Briefings in Bioinformatics, 23(1), 1–12. https://doi.org/10.1093/bib/bbab523
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
Suphalakshmi, A., Ahilan, A., Jeyam, A., & Subramanian, M. (2022). Cervical cancer classification using EfficientNet and fuzzy extreme learning machine. Journal of Intelligent and Fuzzy Systems, 43(5), 6333–6342. https://doi.org/10.3233/JIFS-220296
Tashtoush, Y., Obeidat, R., Al-Shorman, A., Darwish, O., Al-Ramahi, M., & Darweesh, D. (2023). Enhanced convolutional neural network for non-small cell lung cancer classification. International Journal of Electrical and Computer Engineering, 13(1), 1024–1038. https://doi.org/10.11591/ijece.v13i1.pp1024-1038
Uzun, A., Laliberte, A., Parker, J., Andrew, C., Winterrowd, E., Sharma, S., Istrail, S., & Padbury, J. F. (2012). DbPTB: A database for preterm birth. Database, 2012, 1–10. https://doi.org/10.1093/database/bar069
Walter, W., Pohlkamp, C., Meggendorfer, M., Nadarajah, N., Kern, W., Haferlach, C., & Haferlach, T. (2023). Artificial intelligence in hematological diagnostics: Game changer or gadget? Blood Reviews, 58, 101019. https://doi.org/10.1016/j.blre.2022.101019
Wang, C., Ma, J., Shao, J., Zhang, S., Liu, Z., Yu, Y., & Li, W. (2022). Predicting EGFR and PD-L1 status in NSCLC patients using multitask AI system based on CT images. Frontiers in Immunology, 13, 1–12. https://doi.org/10.3389/fimmu.2022.813072
Wang, X., Chen, P., Ding, G., Xing, Y., Tang, R., Peng, C., Ye, Y., & Fu, Q. (2021). Dual-scale categorization based deep learning to evaluate programmed cell death ligand 1 expression in non-small cell lung cancer. Medicine, 100(20), e25994. https://doi.org/10.1097/MD.0000000000025994
Wu, J., Liu, C., Liu, X., Sun, W., Li, L., Gao, N., Zhang, Y., Yang, X., Zhang, J., Wang, H., Liu, X., Huang, X., Zhang, Y., Cheng, R., Chi, K., Mao, L., Zhou, L., Lin, D., & Ling, S. (2022). Artificial intelligence-assisted system for precision diagnosis of PD-L1 expression in non-small cell lung cancer. Modern Pathology, 35(3), 403–411. https://doi.org/10.1038/s41379-021-00904-9
Yang, Z., Zhou, D., & Huang, J. (2023). Identifying explainable machine learning models and a novel SFRP2+ fibroblast signature as predictors for precision medicine in ovarian cancer. International Journal of Molecular Sciences, 24(23). https://doi.org/10.3390/ijms242316942
Ye, M., Tong, L., Zheng, X., Wang, H., Zhou, H., Zhu, X., Zhou, C., Zhao, P., Wang, Y., Wang, Q., Bai, L., Cai, Z., Kong, F. M., Wang, Y., Li, Y., Feng, M., Ye, X., Yang, D., Liu, Z., … Bai, C. (2022). A classifier for improving early lung cancer diagnosis incorporating artificial intelligence and liquid biopsy. Frontiers in Oncology, 12, 1–10. https://doi.org/10.3389/fonc.2022.853801
Zafar, M. A., Ziganshin, B. A., Li, Y., Ostberg, N. P., Rizzo, J. A., Tranquilli, M., Mukherjee, S. K., & Elefteriades, J. A. (2023). "Big data" analyses underlie clinical discoveries at the aortic institute. Yale Journal of Biology and Medicine, 96(3), 427–440. https://doi.org/10.59249/LNDZ2964
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Faisal Asadi, Ashraf Alif Adillah, Jonathan Lucas Fontana, Michael Dimas Chrispradipta, Mousa Khalil Mousa Ayesh, Wairanatha Halim
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License - Share Alike that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
USER RIGHTS
All articles published Open Access will be immediately and permanently free for everyone to read and download. We are continuously working with our author communities to select the best choice of license options, currently being defined for this journal as follows: Creative Commons Attribution-Share Alike (CC BY-SA)
